Effects of obesity and subsequent weight reduction on left ventricular function

Cardiology in Review

Volumn 19, Issue 1, 2011, Pages 1-4

  Lakhani, Mohan ^a   Fein, Steven ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

bariatric surgery; caloric restriction; cardiac function; echocardiographic findings; gastric bypass; left ventricular function; Obesity; obesity cardiomyopathy; weight loss

Indexed keywords

ADIPOCYTOKINE; CYTOKINE;

BARIATRIC SURGERY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; BARIATRIC SURGERY; ECHOCARDIOGRAPHY; HUMANS; OBESITY; VENTRICULAR FUNCTION, LEFT; WEIGHT LOSS;

EID: 78650779060     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181f877d2     Document Type: Review

References (51)

1. World Health Organization. Available at: Gttp://www.who.int/topics/ obesity/en/.
2. Manson JE, Bassuk SS. Obesity in the United States: A fresh look at its high toll. JAMA. 2003;289:229-230.
3. Sturm R, Wells KB. Does obesity contribute as much to morbidity as poverty or smoking? Public Health. 2001;115:229-235.
4. Hippocrates. Medical Works of Hippocrates. Chadwick J, Mann WN, transed. Boston, MA: Blackwell Scientific Publications; 1950.
5. Snyder EE, Walts B, Perusse L, et al. The human obesity gene map: The 2003 update. Obes Res. 2004;12:369-439.
6. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA. 1986;256:51-54.
7. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111-2119.
8. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972-978.
9. Cigolini M, Targher G, Bergamo Andreis IA, et al. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol. 1996;16:368-374. (Pubitemid 26084311)
10. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196-4200.
11. Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med. 2000;5:391-418.
12. Arcaro G, Zamboni M, Rossi L, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord. 1999;23:936-942.
13. Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diab Res Clin Pract. 2001;54(suppl 2):S29-S33.
14. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434-439.
15. Doehner W, Rauchhaus M, Godsland IF, et al. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol. 2002;83:73-81.
16. Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932-939.
17. Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: Anatomic, metabolic and angiogenic perspectives. Microcirculation. 1997;4:211-232.
18. Larsen OA, Lassen NA, Quaade F. Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand. 1966;66:337-345.
19. Lesser GT, Deutsch S. Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr. J Appl Physiol. 1967;23:621-630.
20. Oberg B, Rosell S. Sympathetic control of consecutive vascular sections in canine subcutaneous adipose tissue. Acta Physiol Scand. 1967;71:47-56.
21. Alpert MA. Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321:225-236.
22. Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: A clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol. 1992;70:921-924.
23. Messerli FH. Cardiopathy of obesity-a not-so-victorian disease. N Engl J Med. 1986;314:378-380.
24. Ku CS, Lin SL, Wang DJ, et al. Left ventricular filling in young normotensive obese adults. Am J Cardiol. 1994;73:613-615.
25. Sasson Z, Rasooly Y, Gupta R, et al. Left atrial enlargement in healthy obese: Prevalence and relation to left ventricular mass and diastolic function. Can J Cardiol. 1996;12:257-263.
26. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471-2477.
27. Smith HL, Willius F. Adiposity of the heart: A clinical and pathologic study of one hundred and thirty-six obese patients. Arch Intern Med. 1933;52:911-931.
28. Roberts WC, Roberts JD. The floating heart or the heart too fat to sink: Analysis of 55 necropsy patients. Am J Cardiol. 1983;52:1286-1289.
29. Carpenter HM. Myocardial fat infiltration. Am Heart J. 1962;63:491-496.
30. Lugo M, Putong PB. Metaplasia. An overview. Arch Pathol Lab Med. 1984;108:185-189.
31. Balsaver AM, Morales AR, Whitehouse FW. Fat infiltration of myocardium as a cause of cardiac conduction defect. Am J Cardiol. 1967;19:261-265.
32. Spain DM, Cathcart RT. Heart block caused by fat infiltration of the interventricular septum (cor adiposum). Am Heart J. 1946;32:659-664.
33. Dervan JP, Ilercil A, Kane PB, et al. Fatty infiltration: Another restrictive cardiomyopathic pattern. Cathet Cardiovasc Diagn. 1991;22:184-189.
34. De Scheerder I, Cuvelier C, Verhaaren R, et al. Restrictive cardiomyopathy caused by adipositas cordis. Eur Heart J. 1987;8:661-663.
35. Turkbey EB, McClelland RL, Kronmal RA, et al. The impact of obesity on the left ventricle: The multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging. 2010;3:266-274.
36. Alpert MA, Hashimi MW. Obesity and the heart. Am J Med Sci. 1993;306: 117-123.
37. Ashrafian H, Le Roux CW, Darzi A, et al. Effects of bariatric surgery on cardiovascular function. Circulation. 2008;118:2091-2102.
38. Savage DD, Levy D, Dannenberg AL, et al. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study). Am J Cardiol. 1990;65:371-376.
39. Bella JN, Devereux RB, Roman MJ, et al. The Strong Heart Study Investigators. Relations of left ventricular mass to fat-free and adipose body mass: The strong heart study. Circulation. 1998;98:2538-2544.
40. Patel RK, Oliver S, Mark PB, et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol. 2009;4:1477-1483.
41. Alpert MA, Lambert CR, Panayiotou H, et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol. 1995;76:1194-1197.
42. Karason K, Wallentin I, Larsson B, et al. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: Survey and intervention study. BMJ. 1997;315:912-916.
43. Hammer S, Van der Meer RW, Lamb HJ, et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab. 2008;93:497-503.
44. Meyer TE, Kovacs SJ, Ehsani AA, et al. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol. 2006;47:398-402.
45. Syed M, Rosati C, Torosoff MT, et al. The impact of weight loss on cardiac structure and function in obese patients. Obes Surg. 2009;19:.
46. Scaglione R, Dichiara MA, Indovina A, et al. Left ventricular diastolic and systolic function in normotensive obese subjects: Influence of degree and duration of obesity. Eur Heart J. 1992;13:738-742.
47. Dorbala S, Crugnale S, Yang D, et al. Effect of body mass index on left ventricular cavity size and ejection fraction. Am J Cardiol. 2006;97:725-729.
48. Her C, Cerabona T, Bairamian M, et al. Right ventricular systolic function is not depressed in morbid obesity. Obes Surg. 2006;16:1287-1293.
49. Wong CY, O'Moore-Sullivan T, Leano R, et al. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110: 3081-3087.
50. Alpert MA, Terry BE, Lambert CR, et al. Factors influencing left ventricular systolic function in nonhypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty. Am J Cardiol. 1993;71:733-737.
51. Syed M, Torosoff M, Rosati C, et al. Effect of comorbidities and medications on left ventricular mass regression after bariatric surgery. J Clin Hypertens (Greenwich). 2010;12:223-227.